Reply to Baklouti et al., “Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?”,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Reply to Baklouti et al., “Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?”
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01908-21
Pier Giorgio Cojutti _{1,

2} , Matteo Rinaldi _{3,

4} , Eleonora Zamparini _{3,

4} , Nicolò Rossi _{3,

4} , Sara Tedeschi _{3,

4} , Matteo Conti ₃ , Federico Pea _{3,

5} , Pierluigi Viale _{3,

4}

Affiliation

We thank Baklouti et al. (1) for commenting on our population pharmacokinetic study of dalbavancin for optimal treatment of adult patients with staphylococcal osteoarticular infections (2) and for suggesting that our model tends to underestimate the ...

中文翻译：